Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy

Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy

Precise drug delivery to tumors with low system toxicity is one of the most important and challenging tasks for pharmaceutical researchers. Despite progress in the field of nanotherapeutics, the use of artificially synthesized nanocarriers still faces several challenges, including rapid clearance fr...

Full description

Bibliographic Details
Main Authors: Yukun Huang, Xiaoling Gao, Jun Chen
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Leukocytes
Tumor
Biomimetic carrier
Nanoparticulate drug  delivery systems
Nanotherapeutics
Cancer therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383517303702

Similar Items

Similar Items